Impact of Adolescent Vaccine Reminder Notices Sent Via Preferred Method of Communication on HPV Vaccination

Not Applicable

Active, not recruiting

• Conditions: Papillomavirus Vaccines
• Interventions: Behavioral: Reminder Sent Via Preferred Method of Communication; Behavioral: Reminder Sent Via Mailed Letter

• Registration Number: NCT05148559
• Lead Sponsor: Huong McLean, PhD

Brief Summary

Vaccine uptake in the United States is lower in rural areas, especially for HPV vaccine. Reminder/recall has been identified as an effective strategy to increase vaccination rates. This study will assess the impact by rurality of vaccine reminder notices sent via the parent's preferred method of communication on HPV vaccination among 12 year-old patients in a regional healthcare system.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-08-12
• Study First Submitted: 2021-11-16
• Study First Submitted QC: 2021-12-02
• Study First Posted: 2021-12-08
• Primary Completion: 2022-11-02
• Status Verified: 2023-04
• Last Update Submitted: 2023-04-21
• Last Update Posted: 2023-04-24
• Study Completion: 2023-12

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 5451

Inclusion Criteria

• Marshfield Clinic Health System patient aged 12 years with at least one preventive visit or two evaluation & management visits with a Marshfield Clinic Health System provider in the last 36 months
• Due for at least one adolescent vaccine (HPV, MenACWY, Tdap)

Exclusion Criteria

• Primary care provider is not affiliated with Marshfield Clinic Health System
• Opted out of Marshfield Clinic Health System vaccine reminder notifications
• Missing or invalid contact information
• Deceased

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Enhanced Reminder	Reminder Sent Via Preferred Method of Communication	-
Standard of Care	Reminder Sent Via Mailed Letter	-

Primary Outcome Measures

Name	Time	Method
Number of patients that received 1 dose of HPV vaccine during follow-up based on electronic health data	90 days	Receipt of 1 dose of HPV vaccine within 90 days of receipt of reminder (yes/no) will be assessed using vaccination data available from the Marshfield Clinic Health System electronic health record, which includes vaccinations administered outside of MCHS through data exchanges with the Wisconsin Immunization Registry. Specifically patients will be classified as having received 1 dose of HPV vaccine if they have record of receipt of HPV vaccine with a vaccination date during the 90-day follow-up period.

Trial Locations

Locations (1)

Marshfield Clinic Health System; 🇺🇸 Marshfield, Wisconsin, United States